ES2175181T3 - Analogos hexaciclicos de camptotecina y su procedimiento de preparacion. - Google Patents

Analogos hexaciclicos de camptotecina y su procedimiento de preparacion.

Info

Publication number
ES2175181T3
ES2175181T3 ES96944606T ES96944606T ES2175181T3 ES 2175181 T3 ES2175181 T3 ES 2175181T3 ES 96944606 T ES96944606 T ES 96944606T ES 96944606 T ES96944606 T ES 96944606T ES 2175181 T3 ES2175181 T3 ES 2175181T3
Authority
ES
Spain
Prior art keywords
hexaciclic
analogs
camptotecine
preparation procedure
camptotechine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96944606T
Other languages
English (en)
Inventor
Angelo Bedeschi
Ilaria Candiani
Franco Zarini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia SpA filed Critical Pharmacia Italia SpA
Application granted granted Critical
Publication of ES2175181T3 publication Critical patent/ES2175181T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS ANALOGOS DE CAMPTOTECINA HEXACICLICA QUE POSEEN UN AZA MIEMBROS UNIDO AL ANILLO (A) DE LA CAMPTOTECINA EN LAS POSICIONES 9 Y 10. DICHOS COMPUESTOS POSEEN UNA IMPORTANTE ACTIVIDAD ANTITUMORAL MEDIANTE LA INHIBICION DE LA TOPOISOMERASA (I).
ES96944606T 1996-01-10 1996-12-17 Analogos hexaciclicos de camptotecina y su procedimiento de preparacion. Expired - Lifetime ES2175181T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9600438.7A GB9600438D0 (en) 1996-01-10 1996-01-10 Hexacyclic camptothecin analogues, and process for preparing them

Publications (1)

Publication Number Publication Date
ES2175181T3 true ES2175181T3 (es) 2002-11-16

Family

ID=10786827

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96944606T Expired - Lifetime ES2175181T3 (es) 1996-01-10 1996-12-17 Analogos hexaciclicos de camptotecina y su procedimiento de preparacion.

Country Status (7)

Country Link
US (1) US5990120A (es)
EP (1) EP0813535B1 (es)
JP (1) JPH11502871A (es)
DE (1) DE69620593T2 (es)
ES (1) ES2175181T3 (es)
GB (1) GB9600438D0 (es)
WO (1) WO1997025332A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702807D0 (en) 1997-02-12 1997-04-02 Pharmacia & Upjohn Spa Alkynyl-substituted camptothecins and process for their preparation
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
CN1946421B (zh) 2004-04-27 2013-07-17 威尔斯达特生物制剂公司 使用病毒和喜树碱进行的癌症治疗
CN1300147C (zh) * 2004-10-18 2007-02-14 中国药科大学 喜树碱衍生物的制备方法
NZ562951A (en) 2005-07-14 2011-09-30 Wellstat Biologics Corp Cancer treatment using a Newcastle disease virus, a fluoropyrimidine and a camptothecin combination
CN100586952C (zh) * 2006-11-10 2010-02-03 中国药科大学 噁唑骈喜树碱酯衍生物及其制备方法和用途
CN102659800B (zh) * 2012-05-11 2014-09-03 中国药科大学 一类低氧激活抗肿瘤化合物及其用途
CA2995029C (en) 2015-09-25 2022-10-25 Zy Therapeutics Inc. Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
CN108017656B (zh) * 2016-11-03 2020-01-07 深圳瀜新生物科技有限公司 喜树碱衍生物及其在制备抗肿瘤药物中的应用
CN109467563B (zh) * 2018-06-08 2021-08-03 浙江大学 一种喜树碱衍生物及其在制备抗炎症药物中的应用
EP3852760A4 (en) * 2018-09-17 2022-05-18 Canget Biotekpharma, LLC MATERIAL OF COMPOSITION, SYNTHESIS, FORMULATION AND APPLICATION OF ANALOGS DERIVED AT POSITIONS 9 AND 7 ON THE FL118 PLATFORM FOR THE TREATMENT OF A HUMAN DISEASE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981968A (en) * 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
GB9319944D0 (en) * 1993-09-28 1993-11-17 Erba Carlo Spa Process for the preparation of 9-amino camptothecin
US5648534A (en) * 1993-12-01 1997-07-15 Ichikawa Gosei Chemical Co., Ltd. Method of producing cis-1-aminoindan-2-ol
US5670500A (en) * 1995-05-31 1997-09-23 Smithkline Beecham Corporation Water soluble camptothecin analogs

Also Published As

Publication number Publication date
JPH11502871A (ja) 1999-03-09
WO1997025332A1 (en) 1997-07-17
US5990120A (en) 1999-11-23
DE69620593D1 (de) 2002-05-16
GB9600438D0 (en) 1996-03-13
EP0813535B1 (en) 2002-04-10
EP0813535A1 (en) 1997-12-29
DE69620593T2 (de) 2002-11-28

Similar Documents

Publication Publication Date Title
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
DK0758248T3 (da) Formuleringer til faktor IX
ES2170102T3 (es) Aminociclohexilesteres y utilizacion de los mismos.
AP1697A (en) Azabicycloalkanes as CCR5 modulators.
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
MX9605807A (es) Cepas de lactobacillus de origen humano, sus composiciones y usos de las mismas.
TR200001603T2 (tr) Yeni bileşikler
ES2106965T3 (es) Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa.
PT641343E (pt) Derivados de 4-mercaptoacetilamino-¬2|benzazapinona (3) e a sua utilizacao como inibidores de encefalinase
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DE69530403D1 (de) Analogen des keratinozytenwachstumfaktors
ES2173858T3 (es) Analogos de huperzina a.
BG102616A (en) Substituted aza- and diazacycloheptane and cyclooctane derivatives and their application
GB2380939B (en) Treatment or prevention of auto-immune diseases
BR9812222A (pt) Preparação farmacêutica separada de complexo de protrombina, preparação diagnóstica, e, utilização de uma preparação
DE69828043D1 (de) Fluoridfreie zahnremineralisierung
NO980296L (no) Forbedrede terapeutiske midler
MY129782A (en) Novel medical use
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
EA200000112A1 (ru) Новая композиция
BG104452A (en) New derivatives of the methylenebisphosphonic acid
MX9304133A (es) Nuevos derivados de los fosfolipidos.
BG99313A (en) 117-alkylketonesteroids as 5- -reductase inhibitors
DE69827017D1 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
ATE75610T1 (de) Pharmazeutische zubereitung zur behandlung des bluthochdrucks.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 813535

Country of ref document: ES